By Bhvita Jani

There was notable growth for the interventional X-ray and mobile C-arm equipment market in 2022, with revenue CAGR of 9.5% and 13.8% respectively, according to a new report from Signify Research. This expansion was supported by several factors, such as healthcare providers prioritising investment in surgical equipment, the prevalent growth of office-based labs and ambulatory surgery centres in the U.S., and the significant progress of structural heart surgery, including procedures such as complex coronary interventions, percutaneous valve repair and replacement and mitral valve replacements.

Product trends

In the mobile C-arm market, flat panel detector (FPD) 3D mobile C-arms are set to outpace growth for 2D C-arm technology, with a revenue CAGR of 8.3% through to 2027. The application of 3D C-arms is proliferating beyond spinal procedures for use in probe guidance in biopsies, and pulmonary procedures and facilitating visualisation of screw placements. The rise of Asian mobile C-arm vendors such as Wandong, Perlong, Allengers, and Kiran X-ray has intensified competition and made 2D mobile C-arm systems more accessible, posing a threat to the demand for image intensifier technology from established vendors. Moreover, reimbursement cuts for pain management clinics in the United States, which are the primary buyers of II, further jeopardise the market.

Within the interventional X-ray market, interventional radiology is experiencing a slowdown due to steady growth in procedural volumes. Interventional neurology is forecast to have the fastest growth due to the emergence of stroke centres in North America and Western Europe facilitating the demand for biplane technology. The market outlook for interventional cardiology remains favourable, with clinical demand maintained by the continued expansion in procedures such as TAVI, TAVR, and mitral and tricuspid valve replacement.

X-Ray Homepage